-
ATTO share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of ATTO shares has decreased $0.59 since the market last closed. This is a 2.60% drop.
-
Closed at $22.14.
The stock has remained unchanged in after-hours trading.
Key terms
About ATTO
Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that creates next-generation biologic medicines for immune-mediated diseases. It was founded in 2022 and is headquartered in San Carlos, CA.
-
Market cap: $1.01B
A market capitalization between $300 million and $2 billion places ATTO in the small capitalization category.
Key terms
Smart score
Latest ATTO news
ATTO Financials
-
ATTO total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
ATTO net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
ATTO earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.
Key terms
ATTO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ATTO Competitors
-
How competitors are chosen
ATTO's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $1.01B
A market capitalization between $300 million and $2 billion places ATTO in the small capitalization category.
